Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (JP25115002)
Japan Society for the Promotion of Science (JP23220009, JP18H05213, JP16H04653, JP17K19445)
Core Research for Evolutional Science and Technology (JPMJCR13W1)
Precursory Research for Embryonic Science and Technology (JPMJPR1684)
Uehara Memorial Foundation
Takeda Science Foundation
Tamura Science and Technology Foundation
Narishige Neuroscience Research Foundation
Received: 25 October 2018
Accepted: 26 December 2018
First Online: 8 January 2019
: All procedures involving the use of animals complied with the guidelines of the National Institutes of Health and were approved by the Animal Care and Use Committee of the University of Toyama.
: Not applicable.
: S.M. owns equity in a company (Gene Therapy Research Institution) that commercializes the use of AAV vectors for gene therapy applications. To the extent that the work in this manuscript increases the value of these commercial holdings, S.M. has a conflict of interest. The other authors declare no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.